OCRINE CANCER RESEARCH
standing of any disease and therefore improving understanding and management options. We aningful impact on how neuroendocrine research is done. The objective of this campaign is to nd in the future. We are so grateful to our community for enabling us to fund this research through preciate it.
SURGICAL SPECIALITY LEAD (SSL) College of Surgeons. There are currently 22 SSLs in the UK, there has never been one in excited about this great opportunity not only to progress research but also to raise awareness of al community. Mr Samuel Ford, a consultant Upper GI and sarcoma surgeon specialising in NET surgery has ncer SSL. He is also the research committee chair of the UK & Ireland Neuroendocrine Tumour mingham. two new trials, train-up approximately 30 new investigators and develop a clinical networks. ue of surgery in advanced neuroendocrine tumours (NETs) which is unknown. NETs are slow might prolong survival and improve quality of life; however, it comes with the risks of undergoing nt groups and NET specialists are united in the value of answering this question although it ce) to surgery or not. This trial is to assess feasibility of recruitment and true acceptability to Surgical Speciality Lead for Neuroendocrine Cancers. I recognise that this is considerable less fund raising and support that has come from our patients, their families and benefactors, ost to consolidate the UK research network for NETs and to target larger funding streams to help rward to hearing about all the progress he will make in this role, and will of course update our
ncer’ podcast where they discuss the entails, how it’s conducted, its vital ore.
Made with FlippingBook flipbook maker